103 related articles for article (PubMed ID: 7520333)
1. Molecular approach to rapid assessment of p53 tumor suppressor mutations in esophageal tumors from stained histological slides.
Whetsell LH; Ringer DP; Schaefer FV
Diagn Mol Pathol; 1994 Jun; 3(2):132-41. PubMed ID: 7520333
[TBL] [Abstract][Full Text] [Related]
2. A frequent alteration of p53 gene in carcinoma in adenoma of colon.
Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M
Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281
[TBL] [Abstract][Full Text] [Related]
3. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219
[TBL] [Abstract][Full Text] [Related]
4. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
5. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K
Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033
[TBL] [Abstract][Full Text] [Related]
6. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations.
Hollstein MC; Peri L; Mandard AM; Welsh JA; Montesano R; Metcalf RA; Bak M; Harris CC
Cancer Res; 1991 Aug; 51(15):4102-6. PubMed ID: 1855226
[TBL] [Abstract][Full Text] [Related]
8. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
[TBL] [Abstract][Full Text] [Related]
9. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
10. p53 gene mutations in gastric adenomas.
Tohdo H; Yokozaki H; Haruma K; Kajiyama G; Tahara E
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(3):191-5. PubMed ID: 8097076
[TBL] [Abstract][Full Text] [Related]
11. Frequent mutation of the p53 gene in human esophageal cancer.
Hollstein MC; Metcalf RA; Welsh JA; Montesano R; Harris CC
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9958-61. PubMed ID: 2263646
[TBL] [Abstract][Full Text] [Related]
12. Ligation of a primer at a mutation: a method to detect low level mutations in DNA.
Kaur M; Zhang Y; Liu WH; Tetradis S; Price BD; Makrigiorgos GM
Mutagenesis; 2002 Sep; 17(5):365-74. PubMed ID: 12202623
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
[TBL] [Abstract][Full Text] [Related]
14. "Hot spots" mutation analysis of p53 gene in gastrointestinal cancers by amplification of naturally occurring and artificially created restriction sites.
Chen PH; Lin SY; Wang CK; Chen YJ; Chen TC; Chang JG
Clin Chem; 1993 Oct; 39(10):2186-91. PubMed ID: 7691445
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.
Lothe RA; Fossli T; Danielsen HE; Stenwig AE; Nesland JM; Gallie B; Børresen AL
J Natl Cancer Inst; 1992 Jul; 84(14):1100-8. PubMed ID: 1619684
[TBL] [Abstract][Full Text] [Related]
16. p53 gene mutations in gastric and esophageal cancers.
Imazeki F; Omata M; Nose H; Ohto M; Isono K
Gastroenterology; 1992 Sep; 103(3):892-6. PubMed ID: 1499939
[TBL] [Abstract][Full Text] [Related]
17. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
Fagin JA; Matsuo K; Karmakar A; Chen DL; Tang SH; Koeffler HP
J Clin Invest; 1993 Jan; 91(1):179-84. PubMed ID: 8423216
[TBL] [Abstract][Full Text] [Related]
19. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
20. p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis.
Tamura G; Maesawa C; Suzuki Y; Satodate R; Ishida K; Saito K
Jpn J Cancer Res; 1992 Jun; 83(6):559-62. PubMed ID: 1644659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]